Abstract
A case of acute hepatocellular and cholestatic liver injury that may have been associated with the use of celecoxib is described. This case was reported to US Food and Drug Administration and the manufacturer of celecoxib. Keywords: celecoxib; COX-2 inhibitors; acute hepatic injury; adverse effects
Full Text
The Full Text of this article is available as a PDF (89.4 KB).